DermTech (DMTK) Peer Comparison

$0.04

$-0.01 (-12.05%)

As on 29-Aug-2024 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$16 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Market cap ($ Mln)	3	809	95
Revenue ($ Mln)	16	182	10
Net Profit ($ Mln)	-89.63	12.56	-83.80
Net Margin (%)	-571.97	6.91	-850.75
RoE (%)	-158.55	5.21	--
Price to Earnings	--	64.50	--
Price-To-Book	0.02	3.39	7.09

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Operating Revenue	15.66	181.60	9.85
Cost of Revenue	14.33	123.35	13.19
Gross Profit	0.28	62.39	-5.03
Operating Expenses	92.24	43.85	67.77
Operating Profit (EBIT)	-90.90	14.41	-71.11
Other Income	0.01	0.00	0.00
Profit before Tax	-89.63	14.38	-83.44
Provision for Tax	0.78	1.82	0.36
Profit after Tax (Net Income)	-89.63	12.56	-83.80
Minority Interest	0.00	0.00	0.00
Consolidated Profit	-31.36	0.00	0.00

Liabilities ($ Mln)

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Shareholder's Funds	39.99	238.87	-11.33
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	50.46	3.94	9.91
Current Liabilities	12.52	17.54	39.92
Total Liabilities	121.93	260.83	60.53

Assets ($ Mln)

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Non-Current Assets	58.77	141.09	19.06
Current Assets	44.20	119.26	19.44
Total Assets	121.93	260.83	60.53
Total Debt*	53.67	0.00	20.43
Net Current Assets	31.68	101.73	-20.48

Cashflow ($ Mln)

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Cash From Operating Activities	-76.98	20.01	-63.63
Cash Flow from Investing Activities	--	--	--
Cash from Financing Activities	6.08	-17.04	9.63
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
ROCE (%)	-67.31	8.04	-108.72
ROE (%)	-158.55	5.21	-117.89
ROA (%)	-58.06	4.48	-100.09
EBIT Margin (%)	-580.39	6.00	-721.18
Net Margin (%)	-571.97	6.91	-850.75
Cash Profit Margin (%)	0.00	0.00	0.00

Growth Ratios

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Revenue Growth (%)	9.71	6.00	39.05
EBIT Growth (%)	24.25	-55.32	9.04
Net Profit Growth (%)	21.57	-53.85	-5.15
EPS Growth (%)	--	-53.85	4.87
Book Value Growth (%)	--	-0.85	-116.25

Valuation Ratios

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Price / Earnings	--	39.03	-1.02
Price / Book Value	--	3.12	2.39
Dividend Yield (%)	--	--	--
EV/EBITDA	0.02	19.95	-0.87
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.08	0.00	-1.45
Current Ratio	3.53	6.80	0.49
Quick Ratio	3.46	2.94	0.31
Interest Coverage	-57.28	118.84	-122.25

Operating Efficiency Ratios

	DermTech (DMTK)	ATRION Corporation (ATRI)	Asensus Surgical (ASXC)
Debtors to sales (%)	15.94	14.62	4.12
Asset Turnover	0.10	0.65	0.12
Receivable days	80.66	50.67	134.53
Inventory Days	33.57	252.92	207.43
Payable days	47.46	31.94	100.56
Cash Conversion Cycle	66.78	271.65	241.39

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly